YAQRIT
Liver cirrhosis kills more than a million people a year. More than 650 million people around the world suffer from chronic liver disease, costing economies €15.8 billion annually. Yaqrit Limited is developing a family of liver disease treatments that will transform the lives of these patients. Today, there are few options for treatment. Antibiotics and laxatives, which target gut bacteria and bacterial products, or a liver transplant are the standards of care. The drawbacks of widespread antibiotic use are well-known, and waiting lists for transplants are long – in the UK, for example, 30% of patients on the waiting list have been there for more than two years.
YAQRIT
Industry:
Biotechnology Health Care Life Science Medical Medical Device Pharmaceutical
Founded:
2015-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.yaqrit.com
Total Employee:
1+
Status:
Active
Total Funding:
17.85 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Apache Wordpress Plugins
Similar Organizations
Catalyst Biosciences
Catalyst Biosciences is a drug r and d company creating catalytic biopharmaceutical products based on engineered human proteases.
CeQur
CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Employees Featured
Founder
Investors List
Trend Investment Group
Trend Investment Group investment in Convertible Note - Yaqrit
Riveria Investment Group
Riveria Investment Group investment in Private Equity Round - Yaqrit
Horizon 2020
Horizon 2020 investment in Grant - Yaqrit
UCLB
UCLB investment in Angel Round - Yaqrit
Horizon 2020
Horizon 2020 investment in Grant - Yaqrit
Official Site Inspections
http://www.yaqrit.com
- Host name: webmate.me
- IP address: 5.254.160.149
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Yaqrit"
Yaqrit - Crunchbase Company Profile & Funding
Yaqrit, a clinical-stage company, is dedicated to pioneering innovative treatments for patients suffering from advanced liver disease, particularly those facing …See details»
Yaqrit 2025 Company Profile: Valuation, Funding & Investors
When was Yaqrit founded? Yaqrit was founded in 2014. Where is Yaqrit headquartered? Yaqrit is headquartered in Ledbury, United Kingdom. What is the size of Yaqrit? Yaqrit has 5 total …See details»
Yaqrit appoints new CEO Troels Jordansen to implement late …
Email: [email protected] Tel: +31 6 1934 5326 Contact Investors Mary-Ann Chang Email: [email protected] Tel: +44 7483 284 853 About Yaqrit Yaqrit is a clinical-stage company …See details»
Yaqrit Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Mar 8, 2025 Explore Yaqrit Ltd. with its drug pipeline, therapeutic area, technology platform, 5 clinical trials, 2 news, and 2 literature, Disease Domain:Nervous System Diseases, …See details»
Yaqrit - Funding, Financials, Valuation & Investors - Crunchbase
Yaqrit is a clinical-stage company discovering and developing treatments for patients with advanced liver disease. ... Experience the new Crunchbase, powered by AI . Experience the …See details»
Yaqrit Ltd. - A-TANGO
Yaqrit Discovery Ltd. is a clinical-stage life sciences company developing innovative treatments for patients with advanced liver disease in areas of high unmet medical need. Three of its …See details»
Yaqrit - VentureRadar
Yaqrit is developing treatments for liver disease. Twenty years of work in liver disease has led to a family of breakthroughs, now combined with experienced management to bring new …See details»
Yaqrit - Contacts, Employees, Board Members, Advisors & Alumni
Yaqrit Limited is a UK-based company specialising in interventions in liver disease based on 20 years of research and development at UCL. Search Crunchbase. Start Free Trial . Chrome …See details»
Yaqrit Company Profile | Management and Employees List
Yaqrit is a clinical stage life sciences company focused on developing potentially innovative treatments for patients with advanced liver disease in areas of high unmet medical need. The …See details»
Yaqrit - Products, Competitors, Financials, Employees, …
Contact Company Troels Jordansen, CEO Email: [email protected] Tel: +31 6 1834 5326 Contact Investors Mary-Ann Chang Email: [email protected] Tel: +44 7483 284 853 …See details»
Yaqrit Company Profile - Office Locations, Competitors, Revenue
Yaqrit is a biotech company developing liver disease treatments. Its technology focuses on the removal of bacterial endotoxins from the blood and from the gut. The company offers …See details»
Yaqrit Discovery Ltd. - Drug pipelines, Patents, Clinical trials
Explore Yaqrit Discovery Ltd. with its drug pipeline, therapeutic area, technology platform, 5 clinical trials, 3 news, and 2 literature, Drug:Resatorvid. ... The statistics for drugs in the …See details»
Yaqrit - Crunchbase
Yaqrit Limited is a UK-based company specialising in interventions in liver disease based on 20 years of research and development at UCL. Search Crunchbase. Start Free Trial . Chrome …See details»
New treatment for cirrhosis, alcoholic and non-alcoholic fatty liver ...
Apr 15, 2015 Yaqrit is the pioneer UK company developing new treatments in liver disease, one of the top five causes of mortality. Deaths related to liver disease worldwide have almost …See details»
Yaqrit Discovery Ltd | Riveria
Yaqrit Discovery Ltd. Founded: 2001. Invested: 2020. Headquartered: London, UK. Yaqrit is a clinical stage liver disease company, spun out of University College London in 2014. The …See details»
Yaqrit strengthens board and senior management
Feb 21, 2025 Email: [email protected]. Tel: +31 6 1834 5326. Contact Investors. Mary-Ann Chang. Email: [email protected]. Tel: +44 7483 284 853. About Yaqrit. Yaqrit is a clinical …See details»
Yaqrit strengthens board and senior management ahead of multi …
Feb 21, 2025 Yaqrit. Ex-Takeda VP Tauhid Ali, Ph.D., with broad leadership and drug development experience becomes Board Director. Seasoned regulatory strategist Darren …See details»
Yaqrit strengthens board and senior management ahead of multi …
Feb 21, 2025 Yaqrit's pipeline includes three novel therapeutics at phase 2-3 of development and two medical devices providing acute and chronic treatments for advanced cirrhosis and …See details»
Yaqrit - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Yaqrit is a clinical-stage company discovering and developing treatments for patients with advanced liver disease. ... Pricing. Log In. Log In. Experience the new Crunchbase, powered …See details»
Yaqrit appoints new CEO Troels Jordansen to implement late …
Jan 10, 2025 Yaqrit is a clinical-stage company discovering and developing innovative treatments for patients with advanced liver disease at high risk of hospitalization and death. …See details»